Torrent Pharmaceuticals Completes Acquisition of JB Chemicals Shares, Now Holds 48.80% Stake

1 min read     Updated on 03 Feb 2026, 10:11 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Torrent Pharmaceuticals Limited has completed its acquisition of J.B. Chemicals & Pharmaceuticals Limited shares, acquiring the final 92,490 equity shares (0.06% stake) from a JB Chemicals employee on February 3, 2026. The company now holds 7,83,57,892 equity shares, representing 48.80% of JB Chemicals' equity share capital on a fully diluted basis. All shares under both the primary Share Purchase Agreement dated June 29, 2025, and the employee share purchase agreement dated July 3, 2025, have been successfully acquired, completing the strategic acquisition program.

31682506

*this image is generated using AI for illustrative purposes only.

Torrent Pharmaceuticals has successfully completed its strategic acquisition of equity shares in J.B. Chemicals & Pharmaceuticals Limited, marking a significant milestone in the pharmaceutical sector consolidation. The company announced on February 3, 2026, that it has acquired the final tranche of shares under its comprehensive acquisition agreements.

Final Share Acquisition Details

The latest acquisition involved 92,490 equity shares of JB Chemicals, purchased from an employee of the target company. This transaction was executed in accordance with the share purchase agreement dated July 3, 2025, which was specifically designed for acquiring shares from JB Chemicals employees.

Transaction Details: Specifications
Shares Acquired: 92,490 equity shares
Percentage of Capital: 0.06%
Acquisition Date: February 3, 2026
Agreement Date: July 3, 2025
Seller: JB Chemicals Employee

Completion of Acquisition Program

Torrent Pharmaceuticals has confirmed that all equity shares targeted under its dual acquisition strategy have been successfully acquired. The acquisition program comprised two main agreements: the primary Share Purchase Agreement dated June 29, 2025, executed between Torrent Pharmaceuticals, Tau Investment Holdings Pte Limited, and JB Chemicals, and the supplementary employee share purchase agreement dated July 3, 2025.

Current Shareholding Position

Following the completion of this acquisition, Torrent Pharmaceuticals' total shareholding in JB Chemicals has reached a substantial position in the pharmaceutical company.

Shareholding Summary: Details
Total Shares Held: 7,83,57,892 equity shares
Ownership Percentage: 48.80%
Basis: Fully diluted equity share capital
Status: Acquisition program completed

Regulatory Compliance and Documentation

The acquisition has been conducted in full compliance with SEBI regulations, specifically under Regulation 30 and Regulation 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Torrent Pharmaceuticals has maintained transparency throughout the acquisition process, with multiple intimations to stock exchanges dating back to June 29, 2025.

The completion of this acquisition represents a strategic expansion for Torrent Pharmaceuticals in the pharmaceutical sector, establishing a significant stake in JB Chemicals & Pharmaceuticals Limited. The systematic approach to the acquisition, involving both institutional and employee shareholdings, demonstrates the company's comprehensive strategy for building substantial positions in target companies.

Historical Stock Returns for Torrent Pharmaceuticals

1 Day5 Days1 Month6 Months1 Year5 Years
+0.51%+1.33%+2.87%+12.79%+31.25%+212.58%
Torrent Pharmaceuticals
View Company Insights
View All News
like15
dislike

Torrent Pharmaceuticals Records ₹24.83 Crore Block Trade on NSE

1 min read     Updated on 03 Feb 2026, 09:43 AM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Torrent Pharmaceuticals Ltd. executed a major block trade on NSE worth ₹24.83 crores, involving 61,261 shares at ₹4,053.50 per share. The transaction reflects significant institutional investor activity and demonstrates continued market interest in the pharmaceutical company through the block deal mechanism.

31637582

*this image is generated using AI for illustrative purposes only.

Torrent Pharmaceuticals Ltd. recorded a significant block trade on the National Stock Exchange (NSE), highlighting notable institutional trading activity in the pharmaceutical sector. The transaction represents a substantial movement of shares through the block deal mechanism.

Block Trade Details

The block trade executed on NSE involved a considerable transaction value and volume, demonstrating institutional investor participation in Torrent Pharmaceuticals' stock.

Parameter: Details
Transaction Value: ₹24.83 crores
Number of Shares: 61,261 shares
Price per Share: ₹4,053.50
Exchange: NSE

Market Significance

Block trades represent large-volume transactions typically executed by institutional investors, mutual funds, or other significant market participants. These transactions are conducted through a separate window to minimize the impact on regular market trading and provide liquidity for large-scale share transfers.

The execution price of ₹4,053.50 per share reflects the prevailing market conditions at the time of the transaction. Such block deals often indicate strategic portfolio adjustments by institutional investors or significant stake changes in the company.

Transaction Overview

The block trade mechanism allows for efficient execution of large orders without causing significant price volatility in the regular trading session. This particular transaction involving Torrent Pharmaceuticals demonstrates the continued interest of institutional investors in the pharmaceutical sector, with the substantial transaction value indicating confidence in the company's market position.

Historical Stock Returns for Torrent Pharmaceuticals

1 Day5 Days1 Month6 Months1 Year5 Years
+0.51%+1.33%+2.87%+12.79%+31.25%+212.58%
Torrent Pharmaceuticals
View Company Insights
View All News
like15
dislike

More News on Torrent Pharmaceuticals

1 Year Returns:+31.25%